Torsades de pointe (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Torsades de pointe" in French language version.

refsWebsite

Global rank French rank

3ahajournals.org

3,608^th place

659^th place

2ama-assn.org

3,257^th place

1,028^th place

2nih.gov

4^th place

12^th place

2annals.org

low place

1,894^th place

1bmj.com

1,226^th place

347^th place

1issn.org

57^th place

4^th place

1doi.org

2^nd place

3^rd place

1onlinejacc.org

low place

2,587^th place

1wiley.com

222^nd place

129^th place

ahajournals.org

circ.ahajournals.org

(en) Sauer AJ, Newton-Cheh C, Clinical and genetic determinants of torsade de pointes risk Circulation, 2012;125:1684-1694
(en) Moss AJ, Schwartz PJ, Crampton RS et al. « The long QT syndrome: prospective longitudinal study of 328 families » Circulation, 1991;84:1136–1144
Drew BJ, Ackerman MJ, Funk M, Prevention of torsade de pointes in hospital settings, a scientific statement from the American Heart Association and the American College of Cardiology Foundation, circulation, 2010;121:1047-1060

ama-assn.org

jama.ama-assn.org

(en) Makkar RR, Fromm BS, Steinman RT, Meissner MD, Lehmann MH, « Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs » JAMA, 1993;270:2590– 2597
(en) Honig PK, Wortham DC, Zamani K, Conner DP, Mullin JC, Cantilena LR, « Terfenadine-ketoconazole interaction: pharmacokinetic and electrocardiographic consequences » JAMA, 1993;269:1513–1518

annals.org

(en) Wilt JL, Minnema AM, Johnson RF, Rosenblum AM, « Torsade de pointes associated with the use of intravenous haloperidol » Ann Intern Med, 1993;119:391–394
(en) Krantz MJ, Lewkowiez L, Hays H, Woodroffe MA, Robertson AD, Mehler PS, « Torsade de pointes associated with very-high-dose methadone » Ann Intern Med, 2002;237:501–504

bmj.com

(en) Hennessy S, Bilker WB, Knauss JS, Margolis DJ et al. « Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data » BMJ, 2002;325:1070

doi.org

dx.doi.org

Yaron Arbel, Michael Swartzon et Dan Justo, « QT prolongation and Torsades de Pointes in patients previously treated with anthracyclines », Anti-Cancer Drugs, vol. 18, n^o 4,‎ avril 2007, p. 493–498 (ISSN 0959-4973, PMID 17351403, DOI 10.1097/CAD.0b013e328012d023, lire en ligne, consulté le 19 septembre 2017)

issn.org

portal.issn.org

Yaron Arbel, Michael Swartzon et Dan Justo, « QT prolongation and Torsades de Pointes in patients previously treated with anthracyclines », Anti-Cancer Drugs, vol. 18, n^o 4,‎ avril 2007, p. 493–498 (ISSN 0959-4973, PMID 17351403, DOI 10.1097/CAD.0b013e328012d023, lire en ligne, consulté le 19 septembre 2017)

nih.gov

ncbi.nlm.nih.gov

Roden DM, Cellular basis of drug-induced torsades de pointes, Br J Pharmacol, 2008;154:1502-1507
Yaron Arbel, Michael Swartzon et Dan Justo, « QT prolongation and Torsades de Pointes in patients previously treated with anthracyclines », Anti-Cancer Drugs, vol. 18, n^o 4,‎ avril 2007, p. 493–498 (ISSN 0959-4973, PMID 17351403, DOI 10.1097/CAD.0b013e328012d023, lire en ligne, consulté le 19 septembre 2017)

onlinejacc.org

content.onlinejacc.org

Zipes DP, Camm AJ, Borggrefe M et Als. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines, J Am Coll Cardiol, 2006;48:e247–e346

wiley.com

www3.interscience.wiley.com

Pinski SL, Eguía LE, Trohman RG, What is the minimal pacing rate that prevents torsades de pointes? Insights from patients with permanent pacemakers, Pacing Clin Electrophysiol, 2002;25:1612–1615